BMS, AstraZeneca Collaborating on Two Diabetes Drugs

Drug Industry Daily
A A

Bristol-Myers Squibb (BMS) and AstraZeneca announced that they are collaborating to develop and commercialize two experimental drugs for Type 2 diabetes.

To View This Article:

Login

Subscribe To Drug Industry Daily